Hi all - The FDA today approved the use of ponatinib for resistant CML three months earlier than expected. You can find details here:
http://www.medpagetoday.com/HematologyOncology/Leukemia/36462?utm_source=bre aking-news <http://www.medpagetoday.com/HematologyOncology/Leukemia/36462?utm_source=br eaking-news&utm_medium=email&utm_campaign=breaking-news> &utm_medium=email&utm_campaign=breaking-news Dr. Jorge Cortes from MD Anderson, clinical trial lead investigator, puts the drug in perspective for us in this video from ASH last weekend: Study Brings Positive Results For the Most Resistant Types of CML http://www.patientpower.info/video/study-brings-positive-results-for-the-mos t-resistant-types-of-cml?autoplay=1 Nice to have more support in our tool chest should we need it! Best regards, Pat Elliott CML patient and advocate -- [CMLHope] A support group of http://cmlhope.com ------------------------------------------------- You received this message because you are subscribed to the Google Groups "CMLHope" group. To post to this group, send email to [email protected] To unsubscribe from this group, send email to [email protected] For more options, visit this group at http://groups.google.com/group/CMLHope
